Effects of local application of dopaminergic drugs into the medial prefrontal cortex of rats on latent inhibition

Biological Psychiatry

Volumn 40, Issue 11, 1996, Pages 1083-1090

  Broersen, Laus M ^a   Heinsbroek, Rob P W ^a   De Bruin, Jan P C ^a   Olivier, Berend ^b,c  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b Solvay Pharmaceuticals Inc   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

attention; dopamine; latent inhibition; microinfusions; prefrontal cortex; schizophrenia

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; FLUPENTIXOL;

ANIMAL EXPERIMENT; ARTICLE; ATTENTION; CONDITIONING; INTRACEREBRAL DRUG ADMINISTRATION; LATENT INHIBITION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

EID: 0030560878     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(95)00595-1     Document Type: Article

References (65)

1. Bannon MJ, Roth RH (1983): Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35:53-68.
2. Beckstead RM (1978): An autoradiographic examination of corticocortical and subcortical projections of the mediodorsal-projection (prefrontal) cortex in the rat. J Comp Neurol 184:43-62.
3. Berger B, Gaspar P, Verney C (1991): Dopaminergic innervation of the cerebral cortex: Unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
4. Berman KF, Weinberger DR (1990): The prefrontal cortex in schizophrenia and other neuropsychiatric diseases: In vivo physiological correlates of cognitive deficits. In Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds), Progress in Brain Research, Vol. 85: The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam: Elsevier, pp 521-537.
5. Brito GNO, Thomas GJ, Davis BJ, Gingolg SI (1982): Prelimbic cortex, mediodorsal thalamus, septum, and delayed alternation in rats. Exp Brain Res 46:52-58.
6. Broersen LM, Heinsbroek RPW, De Bruin JPC, Joosten RNJMA, Van Rest A, Olivier B (1994a): Effects of local application of dopaminergic drugs into the dorsal part of the prefrontal cortex of rats in a delayed matching to position task: Comparison to local cholinergic blockade. Brain Res 645:113-122.
7. Broersen LM, Heinsbroek RPW, De Bruin JPC, Olivier B (1994b): Prefrontal dopamine is involved in the discriminative stimulus properties of pentylenetetrazole (PTZ) and in anxiety. Behav Pharmacol 5(suppl 1):31-32.
8. Broersen LM, Heinsbroek RPW, De Bruin JPC, Uylings HBM, Olivier B (1995a): The role of the medial prefrontal cortex of rats in short-term memory functioning: Further support for involvement of cholinergic, rather than dopaminergic mechanisms. Brain Res 674:221-229.
9. Broersen LM, Heinsbroek RPW, De Bruin JPC, Laan J-B, Joosten RNJMA, Olivier B (1995b): Local pharmacological manipulations of prefrontal dopamine affect conflict behaviour in rats. Behav Pharmacol 6:395-404.
10. Bubser M (1994): 6-Hydroxydopamine lesions of the medial prefrontal cortex of rats do not affect dopamine metabolism in the basal ganglia at short and long postsurgical intervals. Neurochem Res 19:421-425.
11. Bubser M, Koch M (1994): Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology 113:487-492.
12. Bubser M, Schmidt WJ (1990): 6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav Brain Res 37:157-168.
13. Bubser M, Schmidt WJ (1994): Injection of apomorphine into the medial prefrontal cortex of the rat increases haloperidol-induced catalepsy. Biol Psychiatry 36:64-67.
14. Carter CJ, Pycock CJ (1980): Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat. Brain Res 192:163-176.
15. Corwin JV, Kanter S, Watson RT, Heilman KM, Valenstein E, Hashimoto A (1986): Apomorphine has a therapeutic effect on neglect produced by unilateral dorsomedial prefrontal cortex lesions in rats. Exp Neurol 94:683-689.
16. De Brabander JM, De Bruin JPC, Van Eden CG (1991): Comparison of the effects of neonatal and adult medial prefrontal cortex lesions on food hoarding and spatial delayed alternation. Behav Brain Res 42:67-75.
17. De la Casa LG, Ruiz G, Lubow RE (1993): Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: Implications for schizophrenia. Biol Psychiatry 33:707-711.
18. Deutch AY (1992): The regulation of subcortical dopamine systems by the prefrontal cortex: Interactions of central dopamine systems and the pathogenesis of schizophrenia. J Neural Transm 36(suppl):61-89.
19. Duvauchelle CL, Levitin M, MacConell LA, Lee LK, Ettenberg A (1992): Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res 576: 104-110.
20. Feldon J, Weiner I (1989): Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats. Pharmacol Biochem Behav 32:123-127.
21. Feldon J, Weiner I (1991a): An animal model of attention deficit. In Boulton A, Baker G, Martin-Iverson M (eds), Neuromethods, Vol. 18: Animal Models in Psychiatry I. New York: Humana Press, pp 313-361.
22. Feldon J, Weiner I (1991b): The latent inhibition model of schizophrenic attention disorder: Haloperidol and sulpiride enhance rat's ability to ignore irrelevant stimuli. Biol Psychiatry 29:635-646.
23. Feldon J, Weiner I (1992): From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiat Res 26:345-366.
24. Feldon J, Shofel A, Weiner I (1991): Latent inhibition is unaffected by direct dopamine agonists. Pharmacol Biochem Behav 38:309-314.
25. Frysztak RJ, Neafsey EJ (1991): The effect of medial frontal cortex lesions on respiration, "freezing," and ultrasonic vocalizations during conditioned emotional responses in rats. Cerebral Cortex 1:418-425.
26. Fuster JM (1989): The Prefrontal Cortex. New York: Raven Press.
27. Grace AA (1991): Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24.
28. Groenewegen HJ, Berendse HW, Wolters JG, Lohman AHM (1990): The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. In Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds), Progress in Brain Research, Vol. 85: The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam: Elsevier, pp 95-118.
29. Jaskiw GE, Weinberger DR, Crawley JN (1991): Microinjection of apomorphine into the prefrontal cortex of the rat reduces dopamine metabolite concentrations in microdialysate from the caudate nucleus. Biol Psychiatry 29:703-706.
30. Koch M, Bubser M (1994): Deficient sensorimotor gating after 6-hydroxydopamine lesion of the rat medial prefrontal cortex is reversed by haloperidol. Eur J Neurosci 6:1837-1845.
31. Kolb B (1990): Animal models for human PFC-related disorders. In Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds), Progress in Brain Research, Vol. 85: The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam: Elsevier, pp 501-519.
32. Leonard CM (1969): The prefrontal cortex of the rat: I. Cortical projections of the mediodorsal nucleus. II. Efferent connections. Brain Res 12:321-343.
33. Lindvall O, Björklund A (1984): General organization of cortical monoamine systems. In Descarries L, Reader TR, Jasper HH (eds), Monoamine Innervation of the Cerebral Cortex. New York: Liss, pp 9-40.
34. Louilot A, Le Moal M, Simon H (1989): Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens: An in vivo voltammetric study. Neuroscience 29:45-56.
35. Lubow RE (1989): Latent Inhibition and Conditioned Attention Theory. Cambridge, UK: Cambridge University Press.
36. Myers RD (1974): Drug and Chemical Stimulation of the Brain. New York: Van Nostrand Reinhold.
37. Oades RD, Rivet JM, Taghzouti K, Kharouby M, Simon H, Le Moal M (1987): Catecholamines and conditioned blocking: Effects of ventral tegmental, septal and frontal 6-hydroxydopamine lesions in rats. Brain Res 406:136-146.
38. Paxinos G, Watson C (1982): The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press.
39. Powell DA, Buchanan SL, Gibbs CM (1990): Role of the prefrontal-thalamic axis in classical conditioning. In Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds), Progress in Brain Research, Vol. 85: The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam: Elsevier, pp 433-466.
40. Pycock CJ, Carter CJ, Kerwin RW (1980): Effects of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. J Neurochem 34:91-99.
41. Robbins TW (1990): The case for frontostriatal dysfunction in schizophrenia. Schizophr Bull 16:391-402.
42. Routtenberg A (1972): Intracranial chemical injection and behavior: A critical review. Behav Biol 7:601-641.
43. Scatton B, Worms P, Lloyd KG, Bartholini G (1982): Cortical modulation of striatal function. Brain Res 232:331-343.
44. Sesack SR, Pickel VM (1992): Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160.
45. Sesack SR, Deutch AY, Roth RH, Bunney BS (1989): Topographical organization of the efferent projections of the medial prefrontal cortex of the rat: An anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-240.
46. Simon H, Scatton B, Le Moal M (1980): Dopaminergic A10 neurons are involved in cognitive functions. Nature 286:150-151.
47. Snapper AC, Inglis GB (1985): SKED-11: Reference Manual. Kalamazoo, MI: State Systems Inc.
48. Snyder SH, Bannerjee SP, Yamamura HI, Greenberg D (1974): Drugs, neurotransmitters and schizophrenia: Phenothiazines, amphetamines, and enzymes synthesizing psychotomimetic drugs aid schizophrenia research. Science 184:1243-1253.
49. Solomon PR, Staton DM (1982): Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiatry 17:743-756.
50. Solomon PR, Crider A, Winkelman JW, Turi A, Kamer RM, Kaplan LJ (1981): Disrupted latent inhibition in the rat with amphetamine or haloperidol-induced supersensitivity: Relationship to schizophrenic attention disorder. Biol Psychiatry 16:519-537.
51. Swanson LW (1981): A direct projection from Ammon's horn to prefrontal cortex in the rat. Brain Res 217:150-154.
52. Swerdlow NR, Braff DL, Masten VL, Geyer MA (1990): Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology 101:414-420.
53. Swerdlow NR, Caine SB, Geyer MA (1992): Regionally selective effects of intracerebral dopamine infusion on sensorimotor gating of the startle reflex in rats. Psychopharmacology 108:189-195.
54. Tarrasch R, Weiner I, Rawlins JNP, Feldon J (1992): Disruption of latent inhibition by interrupting the subicular input to nucleus accumbens and its antagonism by haloperidol. J Psychopharmacol 6:11.
55. Tassin JP (1987): Dopamine and mental illness: And what about the mesocortical dopamine system? Behav Brain Sci 10:224-225.
56. Uylings HBM, Van Eden CG (1990): Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. In Uylings HBM, Van Eden CG, De Bruin JPC, Corner MA, Feenstra MGP (eds), Progress in Brain Research, Vol. 85: The Prefrontal Cortex: Its Structure, Function and Pathology. Amsterdam: Elsevier, pp 31-62.
57. Van Eden CG, Lamme VAF, Uylings HBM (1992): Heterotopic cortical afferents to the medial prefrontal cortex in the rat. A combined retrograde and anterograde tracer study. Eur J Neurosci 4:77-97.
58. Vargo JM, Richard-Smith M, Corwin JV (1989): Spiroperidol reinstates asymmetries in neglect in rats recovered from left or right dorsomedial prefrontal cortex lesions. Behav Neurosci 103:1017-1027.
59. Vezina P, Blanc G, Glowinski J, Tassin JP (1991): Opposed behavioural outputs of increased dopamine transmission in prefrontocortical and subcortical areas: A role for the cortical D-1 dopamine receptor. Eur J Neurosci 3:1001-1007.
60. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
61. Weiner I, Feldon J (1987): Facilitation of latent inhibition by haloperidol. Psychopharmacology 91:248-253.
62. Weiner I, Israeli-Telerant A, Feldon J (1987): Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine. Psychopharmacology 91:345-351.
63. Weiner I, Lubow RE, Feldon J (1988): Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871-878.
64. Winn P (1994): Schizophrenia research moves to the prefrontal cortex. Trends Neurosci 17:265-268.
65. Young AMJ, Joseph MH, Gray JA (1993): Latent inhibition of conditioned dopamine release in rat nucleus accumbens. Neuroscience 54:5-9.